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Influence of antibiotics on Staphylococcus epidermidis biofilms 
Abstract 
 
Staphylococcus epidermidis is a member of the coagulase-negative staphylococci and has 
gained substantial interest in recent years because it has become the most frequently cause of 
infections related to indwelling medical devices. Since S. epidermidis is resistant to some antibiotic 
treatments, it is of major importance to understand the mechanisms and the bacterial components 
involved in those mechanisms. 
Therefore, the present dissertation aimed to understand the mechanisms and the bacterial 
components involved in the antibacterial resistance mechanisms. The first goal of this work was 
the evaluation of the activity of different groups of antibiotics, such as cell-wall and protein synthesis 
inhibitors, on S. epidermidis biofilms. Changes on S. epidermidis biofilms were evaluated regarding 
the total biofilms biomass, bacteria viability and biofilm’s matrix changes after treatment. The 
second goal of this work was the evaluation of the influence of antibiotics on the matrix composition 
considering the contribution of PIA and extracellular DNA to the changes referred.  
Antibiotics treatment with the glycopeptides, vancomycin and teicoplanin, had an effect on 
significantly increasing the total biofilm biomass on all strains. Even though these antibiotics were 
effective against biofilm associated bacteria assessed by XTT, by DMMB staining method it become 
obvious that they had an effect on increasing the amount of biofilms matrix. Thus imply that they 
promoted the membrane rupture, enhancing PIA’s production and the formation of a rougher 
biofilm. Results found on the combinated treatment of DNase I plus antibiotics indicated that 
destruction of eDNA by DNase I leads to a decrease in the matrix, and as a result, antibacterial 
agents protein inhibitors, such as rifampicin and gentamicin, act more effectively to reduce the 
biofilm biomass. 
In conclusion, it was possible to evaluate that antibiotic agents promoted alterations on S. 
epidermidis biofilms. It was also possible to conclude that S. epidermidis biofilms from different 
strains showed an enhanced resistance to the application of treatment with glycopeptide 
antibiotics. Those antibiotics are normally reserved for use against multi-resistant staphylococci, 
however from this study data, it is of major importance to have a better understanding of the 
resistance mechanisms and to find different alternatives. 
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1.1 Genus Staphylococcus 
 
Staphylococci are members of the family Micrococcaceae. Staphylococcus spp. are 
characterized by round shaped cells, non-motile, non-spore forming, Gram-positive cocci, which 
are approximately 1 µm in diameter and that usually divide in multiple planes to form grape-like 
clusters (Figure 1) [1],[2]. 
The genus name Staphylococcus is derived from greek terms (staphyle and kokkos) that mean 
“a cluster of grapes”, that is the most known microscopically aspect of these bacteria after gram-
staining [3],[4]. 
 
 (a)       (b) 
 
Figure 1 Staphylococcus (a) Gram-stained (adapted) [5]. (b) Staphylococci organized like a grape cluster 
(adapted) [6]. 
 
More than 30 staphylococcal species have been identified [7], [8]. These species are 
characterized by a cell wall that consists of a thick layer of peptidoglycan with teichoic acids and 
lipoteichoic acids in between, which make them susceptible to lysis with lysostaphin but not with 
lysozyme [7]. Staphylococci are also oxidase-negative and ferment glucose anaerobically [9]. They 
grow either by anaerobic respiration or by fermentation that produces mostly lactic acid [10]. 
Catalase test is important to distinguishing streptococci from staphylococci, since all staphylococci 
can grow in the presence of bile salts and are catalase positive [4]. 
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Staphylococci can be divided into two large groups based on the ability to produce the enzyme 
coagulase that coagulates plasma. The first group, known as coagulase-positive staphylococci, is 
mainly represented by S. aureus and S. intermedius, which can cause a variety of infections ranging 
from cutaneous to systemic infections. The second group is known as coagulase-negative 
staphylococci (CoNS) [11], [12]. They are normal inhabitants of the upper respiratory tract, skin, 
vagina and intestine, being among the most important bacteria that causes various infections in 
humans (e.g., folliculitis, scalded-skin syndrome and boils) [9]. 
CoNS are among the most commonly isolated organisms in the clinical microbiology 
laboratory. Owing to their ubiquitous nature and relative low virulence, CoNS have for a long time 
been considered to be clinically insignificant pathogens [1], [13]. Due to the widespread use of 
implanted medical devices, in recent decades, these bacteria are now considered as important 
causative agents of nosocomial bacteremias, infections of indwelling devices  [14]. 
 
 
Staphylococcus epidermidis is currently the most significant member of the CoNS group. S. 
epidermidis is a Gram-positive bacteria, found on skin and mucous membranes of humans and 
other organisms, representing an important part of its normal microflora, and includes 65 to 90% 
of all staphylococci isolated from these environments [4], [15], [16]. 
Historically, S. epidermidis has been regarded as an innocuous commensal bacterium of the 
human skin. However, nowadays this bacterium is seen as an important pathogen and as emerged 
as one of the most important and frequent causes of nosocomial infection, mainly caused with 
implanted medical devices (Figure 2) [4], [15], [17]. In order to become a pathogen, S. epidermidis 
requires a predisposed host in order to change from a normal inhabitant of the human skin to an 
infectious agent, and therefore has to be described as opportunistic [15].  
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1.2 Biofilm formation process 
 
In 1987, Costerton et al. defined a biofilm as the accumulation of microorganisms and their 
extracellular products to form a highly structured bacterial community on a surface [18]. Biofilm 
formation as a multi-step process is considered the most important virulence factor of S. 
epidermidis [14]. Biofilm formation occurs in four distinct phases – attachment (adhesion), 
accumulation, maturation and detachment [19]. The process starts with the initial adhesion of cells 
to a surface and their subsequent maturation phase. Detachment of cells or cell clusters from an 
existing biofilm can lead to the dissemination of the infection (Figure 3). 
 
 
 
 
 
 
 
 
Figure 2 Scanning electron micrograph of a Staphylococcus biofilm on the inner surface of a 
needleless connector[75]. 
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1.2.1 Adhesion 
 
Initial bacterial adhesion is the first critical step in the development of implanted-associated 
infections. This process depends on bacterial cell surface characteristics and also on the nature of 
the polymer surface [20]. The initial step involves non- specific physicochemical forces (van der 
Waals), hydrophobic interactions and polarity changes [4], [21]. The colonization of an implanted 
device may occur by the microbial direct attachment to the polymer surface or by binding to the 
host matrix proteins which previously coated the biomaterial surface forming the “conditioning 
biofilm” [15]. 
The direct binding to the polymer surface is mediated by several surfaces structures of S. 
epidermidis biofilms, such as the fimbria-like proteins SSP-1 and SSP-2, the major autolysin AtlE 
and teichoic acids [22]–[24]. 
The two related staphylococcal surface proteins, SSP-1 and SSP-2, are fimbria-like polymers 
that were shown to contribute to the adherence to polystyrene surfaces [22]. The atlE gene encodes 
for autolysin and attachment to a polystyrene surface was demonstrated to be mediated, at least 
Figure 3 Schematic overview of the phases involved in Staphylococcus epidermidis biofilm formation 
on a surface [76]. 
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in part, by the surface-associated autolysin AtlE. AtlE is active during the attachment to both 
conditioned and unconditioned polymer surfaces [25]. 
Aside from proteins, polysaccharide intercellular adhesin molecule (PIA), has been also 
associated  with the initial adherence and slime production [25]. In fact, for a long time studies 
were prevalently centered on PIA of S. epidermidis biofilms, considered the major cell-to-cell 
connecting substance. However, recently the attention has been progressively focused also on 
extracellular DNA, another conspicuous component of the biofilm matrix [26]. The atlE gene, 
mentioned above, is necessary for both attachment and biofilm development. Since there is no 
evidence that AtlE protrudes from the bacterial cell surface, rather than a direct role in primary 
attachment, this autolysin may have an indirect role in S. epidermidis biofilm formation by releasing 
of eDNA. In concordance with this hypothesis is the finding that in cultures of atlE-defective S. 
epidermidis mutants the amount of eDNA is dramatically decreased when compared with its level 
in the wild-type strains [27].  
 
Finally, also the host contributes to adhesion in device-related infections particularly with 
staphylococci, as mentioned above. Multiple specific receptors on the cell surface, called adhesins, 
bind to the host molecules, such as glycoprotein components in plasma or components of the host 
extracellular matrix. Many of these proteins belong to a family of microbial surface components 
that recognize adhesive matrix molecules (MSCRAMMs). MSCRAMMs mediate adhesion to various 
host cell types as well as to polymer surfaces coated with host plasma proteins [12]. 
 
 
1.2.2 Accumulation 
 
Following microbial adherence to the implanted medical device, bacteria proliferate and 
accumulate as multilayered cell clusters, resulting in an extensive network of accumulated bacteria 
[19]. The biofilm accumulation involves intercellular aggregation that is mediated by intercellular 
adhesins. These include surface macromolecules such as exopolysaccharide, surface proteins, 
teichoic acids and extracellular DNA originating from lysed cells which are involved in formation of 
extracellular biofilm matrix [14]. 
In Staphylococcus spp., production of PIA by the genes in the intercellular adhesion (ica) 
operon, is nowadays the best-understood mechanism (ica or PIA-dependent mechanism) of biofilm 
formation [14], [28]. PIA is a major component of the extracellular staphylococcal carbohydrate 
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matrix of S. epidermidis [19]. Mack et al. described PIA as a major functional component involved 
in the intercellular adhesion, essential for the accumulation of multilayered S. epidermidis biofilms 
[29]. 
 
PIA is a linear β-1,6-linked glucosaminoglycan, composed of β-1,6-linked N-acetylglucosamine 
residues containing up to 15% de-N-acetylated amino groups and positively charged (Figure 4). 
These positive charges have been shown to have a major biological importance in biofilm formation, 
virulence and immune evasion [19], [30]. 
 
 
 
PIA is synthesized by enzymes encoded by the intercellular adhesion (ica) operon, which is 
more prevalent in colonizing S. epidermidis isolates [19]. The ica locus is composed of an operon, 
icaADBC, which encodes the structural genes required for PIA synthesis. The ica operon comprises 
4 genes: icaA, icaD, icaB and icaC. A fifth gene, the divergently transcribed icaR gene, responsible 
for the transcription of icaADBC is located upstream of the icaA start codon. IcaR gene is a member 
of the TetR family of transcriptional regulators and negatively regulates icaADBC expression [14]. 
The icaA gene product is responsible for N-acetylglucosaminyltransferase activity during PIA 
synthesis. IcaA adds N-acetylglucosamine from UPD-N-acetylglucosamine to the growing PIA chain, 
requiring the icaD gene product for optimal transferase activity. N-acetylglucosamine oligomers 
produced by icaAD reach a maximal length of 20 residues. Only when icaAD is coexpressed with 
icaC, longer oligomer chains are synthesized. The transmembrane protein IcaC plays a putative 
role in externalization, elongation and translocation of the growing polysaccharide to the cell surface 
and is responsible for the production of full-length PIA molecule [19]. The icaB gene product is a 
Figure 4 Structure of PIA [12]. 
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surface-attached protein responsible for decacetylation of the poly-N-acetylglucosamine molecule 
(Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ica locus and biofilm formation are important parameters for staphylococcal colonization 
and survival on implanted medical devices. However, recent publications have revealed the 
emergence of biofilm-positive and ica-negative staphylococcal clinical isolates [31]. In cases of PIA-
negative biofilm formation, adhesive proteins have been suggested to be involved in the 
accumulation phase. In some strains (ica-positive or negative), biofilm formation is mediated by 
specific surface proteins such as accumulation-associated protein (Aap), biofilm-associated protein 
Figure 5 The exopolysaccharide poly-N-acetylglucosamine. a) The exopolysaccharide poly-N-
acetylglucosamine (PIA), a partially de-acetylated β1-6-linked N-acetylglucosamine (GlcNAc) homopolymer 
involved in immune evasion and biofilm aggregation, is synthesized by the membrane-located GlcNAc 
transferase IcaA, which needs the accessory IcaD membrane protein for activity (step 1). The growing PNAG 
chain is probably exported by the IcaC membrane protein (step 2). After export, IcaB de-acetylase, located on 
the cell surface, removes some of the N-acetyl groups, giving the polymer a cationic character that is 
essential for surface attachment (step 3). b) The Ica proteins are encoded by the ica gene locus containing 
the icaADBC operon and the icaR gene, which encodes a regulatory protein. Expression of the icaADBC 
operon is regulated either directly at the icaA promoter or through expression of IcaR (adapted) [17]. 
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(Bap), or Bap homologue (Bhp) [19]. Biochemical and functional properties clearly differentiate 
Aap from other factors that have been implicated in biofilm formation. It was proposed that Aap 
has a role in the anchoring of PIA to cell surface [32]. 
 
 
1.2.3 Maturation and detachment 
 
 Maturation of the S. epidermidis biofilm is characterized by the generation of a slime 
glycocalix, which encases surface-bound organisms in a gelatinous matrix. The slime 
exopolysaccharide is not essential to the overall process of surface colonization, it is thought to 
increase the stability of the biofilm and therefore contribute to a more robust structure and making 
implanted medical devices colonized with slime-positive strains more difficult to treat. 
A mature biofilm is seen as a very heterogeneous arrangement, with a basic community 
structure which comprises several layers, including the main bulk of the biofilm, a linking film, a 
conditioning film and the substratum to which the biofilm is attached [19], [33]. The mature 
structure reveals groups of micro colonies of bacterial cells encased in extracellular polymeric 
substance matrix [34]. The matrix is one of the most distinctive features of microbial biofilm where, 
in addition to PIA and protein, extracellular DNA has also been shown to be important in stabilizing 
the biofilm [35].  
Mature biofilms form a three-dimensional, gel-like, highly hydrated and locally charged 
environment where microorganisms are largely immobilized. Matrix-enclosed micro colonies, 
sometimes described as mushroom-like forms are separated by fluid-filled channels [34]. Liquid 
flow in these channels, allowing diffusion of nutrients and oxygen to all cells in the biofilm [19]. 
At last, individual bacterial cells, capable of actively leaving a biofilm, can arise and spread 
from the surface film on the outer side of the mature biofilm to colonies in distant sites. The 
dispersion of virulent staphylococci has important implications from S. epidermidis biofilm 
infections. Even if cells actively detaching from the biofilm may colonize alternative sites, it can 
also contribute to the toxicology associated with acute infections [19]. 
In contrast to primary attachment and accumulation, detachment is not well understood. 
However, several factors have been proposed to be involved in biofilm detachment including: 
mechanical forces, changes in nutrient concentrations, cessation of production of biofilm building 
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material, and production of detachment factors controlled by quorum-sensing system accessory-
gene regulator (agr) [19]. 
As mentioned, S. epidermidis virulence factors are mainly regulated by the agr locus [15]. The 
quorum-sensing phenomenon is known as the ability of bacteria to signal and sense the state of 
population density in order to change physiological needs under different environments [36]. 
Therefore, quorum-sensing is a strategy of cell-cell communication benefiting the biofilm 
community by controlling unnecessary overpopulation and competition for nutrients with important 
implications for the infectious process (Figure 6) [37]. Quorum sensing molecules have been 
recognized as important virulence regulators and demonstrated to be essential for biofilm 
formation. Vuong et al. (2003) reported that the agr system controls biofilm formation by regulation 
of biofilm factors such as AtlE and δ-toxin [38]. 
 
 
 
 
 
Figure 6 Quorum-sensing phenomenon. Cell to cell communication in a biofilm. Cartoon representing sessile cells 
“talking” to each other [77]. 
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1.3 Importance of S. epidermidis biofilms in clinical practice 
 
In recent years, S. epidermidis has emerged as one of the most important and frequently 
causes of nosocomial infections, mainly associated with implanted medical devices [4], [15], [21]. 
Therefore and as referred above S. epidermidis species subsist both as commensal and as 
pathogenic, creating strategies for the purpose to transform the hospital environment in a new 
ecological niche. In fact, nearly 80 % of the cells involved in biomaterial associated infections are 
S. epidermidis related [12].  
 
Infections caused by S. epidermidis are usually related to immunocompromised, 
immunosuppressed, long-term hospitalized and critically ill patients [19]. These individuals 
represent a very susceptible hosts with a less powerful immune system and that is why it is 
considered an opportunistic pathogen [39]. Physiological changes in S. epidermidis biofilms protect 
the bacteria from the host immune defense system by lowering the sensitivity towards harmful 
molecules. Such immune-evasion tactics enable the bacteria to persist during infection. Yao et al. 
(2005) described changes in S. epidermidis biofilm gene expression, including low metabolism, 
decreased transcription and translation and a change from aerobic production of energy to 
fermentation, resulting in non-aggressive and protected mode of growth that implies that S. 
epidermidis is less sensitive to antibiotics and host immune system and optimally suitable to long-
term survival in the organism [19], [40]. So, early and acute infections are usually associated with 
Staphylococcus aureus biofilms, but S. epidermidis are typically responsible for chronic and 
profound infections, which occur months to years after the medical device implantation [4].  
Furthermore, S. epidermidis infections are often persistent and relapsing and result from a rupture 
in the cutaneous surface, caused by trauma or insertion of a medical device [16]. That can be the 
channel in which bacteria enters the organism and becomes pathogenic [4]. 
The success of S. epidermidis as a pathogen can be explained by its highly adaptive nature, 
inherent genetic variability and intrinsic genetic flexibility, all of which enable it to resist to different 
external environments [40]. In addition to this factor, the increasing number of 
immunocompromised patients, the growing need of medical devices and the extensive use of 
antibiotics and disinfectants on hospital environments leading to antimicrobial resistance, provides 
conditions for a successful bacterial colonization of the implanted medical device [39]. 
 
Influence of antibiotics on Staphylococcus epidermidis biofilms 
13 
 
In addition to implanted medical devices in immunocompromised patients, S. epidermidis is 
also responsible for native valve endocarditis in immunocompetent individuals, that results from 
the interaction between the vascular endothelium and bacteria circulating in the bloodstream [4], 
[21]. Furthermore, cases of wound infection, urinary tract infection, meningitis and pneumonia, 
associated to S. epidermidis have also been reported [4]. 
 
The indwelling medical devices mostly affected by S. epidermidis persistent infections include, 
prosthetic heart valves, urinary catheters and central venous catheters. Currently and in respect to 
S. epidermidis infections, catheter related infections are a major cause of patient morbidity and 
mortality, justifying most of the time the premature device removal and the increase costs and use 
of resources [4], [41]. 
 
In catheter related infections, in particular, the skin insertion site and the catheter hub are the 
two most important infection sources. In the case of short-term catheters, skin contamination is 
the most likely mechanism of pathogenesis, but for long-term catheters, hub contamination is more 
frequent [4]. After skin contamination, bacteria immediately migrate through the insertion site along 
the external surface of the catheter, colonizing the distal intravascular tip of the catheter, and 
making contact with the bloodstream. This ultimately leads to bloodstream infection [4], [41]. 
In long-term catheters the hub contamination is normal, due to the fact that such catheters 
are continuously and regularly manipulated and intercepted and so bacteria are usually more easily 
introduced into the hub by the hands of medical personnel. From the contaminated hub, 
microorganisms migrate through the internal surface of the catheter, where they can cause a 
bloodstream infection [4]. These devices are in direct contact with bloodstream, platelets, plasma 
and host tissue proteins are rapidly absorbed on the surface of intravenous catheters forming a 
conditioning film that enhances bacterial adherence to the medical device (Figure 7). 
The virulence mechanisms referred for catheter related infections by S. epidermidis are in sort 
a way similar to the other implanted medical devices, such as urinary tract catheters, endotracheal 
tubes, contact lenses and voice prostheses. 
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Figure 7 Catheter related bloodstream infections (scheme of the catheter insertion on 
the patient) [78]. 
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1.4 Treatment of biofilm related infections 
 
Traditional treatment of S. epidermidis infections, including those caused by biofilms on 
implanted medical devices, involves the use of conventional antibiotic therapy directed against the 
known or the likely causative strain, being the final choice dependent on the microbiological, 
pharmacological and toxicological properties of the antibacterial agents. Accepted clinical practice 
often includes therapy of combination which of two or more antimicrobials. This approach comes 
with the clinical standard that a broader spectrum of activity of antibiotics is achieved and lower 
concentrations are required, and results in a more effective therapy and less resistance [19]. 
Administration of prophylactic antibiotic therapy to prevent colonization is also common 
practice during surgical insertion of most biomaterials [16]. However, infective complications often 
arise and it has been shown that even in the presence of antibiotics, adherence, colonization and 
the establishment of infection can occur on the surface of implanted medical devices. 
Unfortunately, implant-associated infections are recalcitrant to typical antimicrobial therapy and 
host defenses. These bacterial infections tend to be very difficult to eradicate and relapses occur 
frequently [17]. 
 
 
1.4.1 Antibiotic treatment 
 
A number of factors conspire to render medical device-related infections resistant to standard 
antimicrobial treatment, including the distinct mode of growth displayed by biofilm populations, 
multi-drug bacterial resistance and the increasing prevalence of S. epidermidis as a nosocomial 
pathogen [17]. In Table 1 are shown some of the most used antibiotics on the clinical practice in 
order to eradicate S. epidermidis biofilm associated infections. 
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Table 1 Overview of used antibiotics on Staphylococcus epidermidis biofilms and their mechanism of action 
(adapted) [42], [43]. 
Antibiotic Group Mechanism of action 
Vancomycin 
Glycopeptide 
Inhibits prolongation of 
peptidoglycan in cell wall 
Teicoplanin 
Oxacillin Penicillinase-resistant β-lactam 
Inhibits cross-linking of 
peptidoglycan in cell wall 
Rifampicin Rifamycin 
Inhibits protein synthesis by 
inhibiting RNA-polymerase 
Gentamicin Aminoglycoside 
Inhibits protein synthesis by 
inhibiting the ribosomes 
 
 
1.4.1.1 Cell wall active antibiotics 
Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections 
caused by Gram-positive bacteria, like S. epidermidis. Vancomycin has been shown to be active 
against the majority of strains of this microorganism, both in vitro and in clinical infections. The 
bactericidal action of vancomycin results primarily from inhibition of cell-wall biosynthesis. 
Specifically, vancomycin prevents incorporation of N-acetylmuramic acid (NAM)- and N-
acetylglucosamine (NAG)-peptide subunits from being incorporated into the peptidoglycan matrix 
which forms the major structural component of Gram-positive cell walls. In addition, vancomycin 
alters bacterial-cell-membrane permeability and RNA synthesis [43]–[45]. 
Teicoplanin is also a glycopeptide antibiotic with a spectrum of activity similar to vancomycin. 
Its mechanism of action is to inhibit bacterial cell wall synthesis. Teicoplanin inhibits peptidoglycan 
polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death [46], [43]. 
Finally, oxacillin is a penicillin beta-lactam antibiotic. Oxacillin has in vitro activity against gram-
positive and gram-negative, aerobic and anaerobic bacteria. The bactericidal activity of oxacillin 
results from the inhibition of cell wall synthesis and is mediated through oxacillin binding to 
penicillin binding proteins (PBPs). Oxacillin inhibits the third and last stage of bacterial cell wall 
synthesis [47], [48].  
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1.4.1.2 Protein synthesis inhibitors 
Rifampicin is a bactericidal antibiotic drug of the rifamycin group. Rifampicin is an antibiotic 
that inhibits DNA-dependent RNA polymerase activity in susceptible cells. It is bactericidal and has 
a very broad spectrum of activity against most gram-positive and gram-negative organisms [43], 
[45].  
Gentamycin is an aminoglycoside antibiotic. Aminoglycosides are highly potent, broad-
spectrum antibiotics with many desirable properties for the treatment of life threatening infections.   
Aminoglycosides like gentamicin "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. 
Specifically gentamicin binds to four nucleotides of 16S rRNA and a single amino acid of protein 
S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S 
subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to 
interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted 
into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into 
nonfunctional monosomes [43], [45]. 
 
 
1.4.2 Antimicrobial resistance 
 
The treatment of S. epidermidis infection is very difficult especially due to the increasing 
resistance to antibacterial agents. The frequent use of antibiotics, incorrect diagnosis, inappropriate 
prescribing and the preferential management of patients with broad-range antibiotics promoted the 
rapid spread of resistance even for modern antibacterial agents [49]. 
Antimicrobial resistance has a significant impact on patient outcome by enhancing virulence, 
delaying the administration of appropriate therapy, limiting available therapy and increasing 
hospitalization time and subsequent recovery, leading to increased morbidity and mortality [19]. A 
study carried out by Arciola et al. [48] on antibiotic resistance in exopolysaccharide-forming S. 
epidermidis strains from implant infections found that only 10% of the 342 clinical isolates tested 
were sensitive to all screened antibiotics. In that study, up to 80% of the isolates were ß-lactam 
resistant, 37% were methicillin resistant (MRSE) and 38% were resistant to imipenem. 
Aminoglycoside resistance was also observed in the clinical isolates with a frequency of 31–32%.  
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The glycopeptide antibiotics vancomycin and teicoplanin are normally reserved for use against 
multi-resistant staphylococci; however, due to increasing reliance on these agents, there are reports 
of reduced susceptibility of staphylococci to glycopeptides. The emergence of vancomycin-resistant 
CoNS is not surprising considering the genetic versatility of staphylococci and the overuse of growth 
inhibitory compounds that select for the development of resistant organisms [19], [50].  
Most of the existing reports regarding the mechanism of glycopeptide resistance have focused 
on S. aureus. It appears due to the accumulation of mutations and not due to genetic exchange 
[19]. Cell-wall thickening associated with vancomycin resistance in S. aureus has been reported by 
a number of groups and it is thought to be a pre-requisite for vancomycin resistance in 
staphylococci. Nunes et al [46] characterized the glycopeptide susceptibility profiles and cell-wall 
ultrastructure of three clinical strains of CoNS with reduced susceptibility to glycopeptides, 
including S. epidermidis. It was highlighted that changes in cell-wall thickness were related to 
vancomycin minimum inhibitory concentrations (MICs), indicating that the bacterial cell 
ultrastructure plays an important role in glycopeptide resistance. 
 
Resistance of biofilm populations to antimicrobials has been well documented. The properties 
of biofilms that result in antibiotic resistance may include slow growth, the presence of persisted 
cells, inactivation of antibiotics within the biofilm exopolysaccharide matrix, and limitations on 
antibiotic penetration imparted by the biofilm matrix (Figure 8) [51]. The biofilm environment 
promotes genetic exchange of antimicrobial resistance genes, increasing bacterial virulence and 
contributing to the development of multiresistance phenotypes [52], [19].  
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Treatment with antibiotics may kill planktonic bacteria shed from the biofilm surface; however, 
they fail to eradicate those embedded within the biofilm, which can then subsequently act as a 
local for a relapsing infection [34]. Following standard antibiotic treatment, a minority of drug-
resistant bacteria exist that repopulate the biofilm. Subsequent retreatment of the repopulated 
biofilm results only in a reduction in bacterial number, indicating that the repopulated biofilm is 
much more resistant to treatment [19]. 
 
 
 
 
Figure 8 Antimicrobial agents resistance- schematic comparison between planktonic cell and biofilms 
(adapted). A- Fee-floating cells utilize nutrients but do not have sufficient metabolic activity to deplete substrates from the 
neighborhood of the cells. In contrast, the collective metabolic activity of groups of cells in the biofilm leads to substrate 
concentration gradients and localized chemical environments. Reduced metabolic activity may result in less susceptibility to 
antimicrobials. B- Free-floating cells carry the genetic code for numerous protective stress responses. Planktonic cells, 
however, are readily overwhelmed by a strong antimicrobial challenge. These cells die before stress responses can be 
activated. In contrast, stress responses are effectively implemented in some of the cells in a biofilm at the extense of other 
cells which are sacrificed. C- Free-floating cells neutralize the antimicrobial agent. The capacity of a lone cell, however, is 
insufficient to draw down the antimicrobial concentration in the neighborhood of the cell. In contrast, the collective 
neutralizing power of groups of cells leads to slow or incomplete penetration of the antimicrobial in the biofilm. D- Free-
floating cells spawn protected persister cells. But under permissive growth conditions in a planktonic culture, persisters 
rapidily revert to a susceptible state. In contrast, persister cells accumulate in biofilms because they revert less and readily 
and are physically retained by the biofilm matrix  [79]. 
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At present, conventional systemic therapies, using standard antimicrobial agents, represent 
the main strategy for the treatment and prevention of medical device associated infection. However, 
as detailed above, the available antibiotic therapies are usually ineffective because of the 
phenomenon of multidrug resistance and the resilient nature of adherent biofilm bacteria. As a 
result, effective eradication of the infection often necessitates the removal of the implant and its 
substitution. Importantly, major advances have been made, leading to a greater understanding of 
the complexities of biofilm formation of S. epidermidis and resulting in significant developments in 
the treatment and prevention of infections related to this member of the CoNS group [19], [51]. 
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1.5 Aims and Objectives 
 
S. epidermidis is currently the most significant member of the coagulase-negative 
staphylococci and constitutes the most widespread and persistent species found on skin and 
mucous membranes of the human body, representing an important part of its normal microflora. 
This pathogen has gained substantial interest in recent years because it has become the most 
frequently cause of infections related to indwelling medical devices, mainly due to its capability to 
adhere to surfaces and form multilayered, highly structured biofilms. In fact, the formation of 
biofilms has been considered the main virulence mechanism of S. epidermidis [15], [19]. 
Biofilms are very difficult to eradicate and are a source of many recalcitrant infections, with 
increased costs and used sources. Device-related biofilm infections with sessile populations are up 
to 1000-fold more resistant to antimicrobial agents than their planktonic counterparts [15]. 
Since S. epidermidis is resistant to some antibiotic treatments, it is of major importance to 
understand the mechanisms and the bacterial components involved in those mechanisms. 
 
The first goal of this work is the evaluation of the influence of antibiotic treatment on S. 
epidermidis biofilms. Moreover, changes in matrix composition after treatment with antibiotics were 
considered. The contribution of PIA and extracellular DNA to those changes were analyzed. 
Henceforth, the specific aims of this work are: 
- Study of S. epidermidis biofilms treated with antibiotics (biofilm biomass, PIA’s matrix and 
viable bacteria); 
- Determination of PIA’s contribution on biofilm formation by PIA dot blot; 
- Determination of excretion of extracellular DNA after treatment with antibiotics by 
extracellular DNA extraction; 
- Visualization of S. epidermidis biofilms by scanning electron microscopy. 
 
 
 
 
 
 
 
Influence of antibiotics on Staphylococcus epidermidis biofilms 
22 
 
 
 
Influence of antibiotics on Staphylococcus epidermidis biofilms 
23 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 Materials and Methods 
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2.1 Bacterial strains and growth conditions  
 
In this work, five Staphylococcus epidermidis strains were used: S. epidermidis 1457, S. 
epidermidis 1457ΔatlE, S. epidermidis 10b, S. epidermidis 567 and S. epidermidis 567-1. S. 
epidermidis 1457 was isolated from a catheter related bloodstream infection [53]. S. epidermidis 
1457ΔatlE is derived from the strain 1457, and contains an erythromycin insertion mutation in the 
atlE gene [27]. S. epidermidis 10b is also a clinical isolate, from a central venous catheter infection 
[54]. S. epidermidis 567 is a clinical isolate from a urinary tract catheter infection. Strain 567-1 is 
the agr-mutated derivative from S. epidermidis 567 [55], which contains an erythromycin insertion 
mutation in the accessory gene regulator (Agr) quorum-sensing system. Bacteria were cultivated in 
tryptic soy broth (TSB, Oxoid, England), with erythromycin (10µg/ml; Sigma-Aldrich) added for S. 
epidermidis 1457ΔatlE and S. epidermidis 567-1. 
 
2.2 Minimum inhibitory concentration determination 
 
The minimum inhibitory concentration (MIC) values of vancomycin (Sigma-Aldrich), 
teicoplanin (Sigma-Aldrich), oxacillin (Sigma-Aldrich), rifampicin (Sigma-Aldrich) and gentamicin 
(Sigma-Aldrich) were determined with the broth dilution methods, as recommended by European 
Committee on Antimicrobial Susceptibility Testing (EUCAST). Shortly, bacteria were grown 
overnight on blood agar plates. Several colonies were resuspended in physiologic saline (0.9% 
NaCl) to reach a density of 0.5 McFarland (Cobas Inocheck, Roche, Switzerland). The bacteria 
were diluted 1/100 in Mueller Hinton Broth II Cation Adjusted (CAMH, Oxoid England) and 
combined with an equal volume of the antibiotic solution, to reach a final concentration of 5 ×
105  CFU/mL. After 18 h incubation at 37°C, bacterial growth was evaluated by measuring 
absorbance at 590 nm (Multilabel counter Victor3, PerkinElmer, USA). The MIC was determined 
as the lowest antibiotic concentration at which no bacterial growth was observed.  
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2.3 Biofilm formation 
 
Biofilms were inoculated from overnight cultures on blood agar plates. Several colonies from 
the culture were resuspended in 0.9% NaCl to reach an optical density equal to 0.5 McFarland 
(Cobas Inocheck, Roche, Switzerland). Of these suspensions, 100 µl was added to 10 ml of the 
appropriate medium. S. epidermidis 1457 and S. epidermidis 10b were grown in 10 times diluted 
TSB (1/10 TSB). S. epidermidis 567 biofilms were grown in TSB with 4% NaCl (Sigma-Aldrich, 
Steinheim, Germany) and S. epidermidis 567-1 and S. epidermidis 1457ΔatlE biofilms were grown 
in TSB supplemented with 10 µg/mL erythromycin (Sigma-Aldrich). Then, 200 µl of the bacterial 
suspension was added in each well of a 96-well microtiter plate (Cellstar, Greiner Bio-One, 
Belgium). The plates were incubated statically at 37°C for 24 h. 
 
2.4 Treatment of biofilms with antibiotics 
 
2.4.1 Treatment 
 
After biofilm formation for 24 h, the supernatants were discarded and the biofilms were 
washed once with phosphate-buffered saline (PBS, pH 7.4). The biofilms were treated with 200µl 
of antibiotic solutions, made in 100 times diluted TSB (1/100 TSB). A negative control was 
performed with a biofilm not exposed to the antibiotics. The tested antibiotics and concentrations 
were: vancomycin (40µg/mL, Sigma-Aldrich,), teicoplanin (50µg/mL, Sigma-Aldrich), oxacillin 
(10µg/mL, Sigma-Aldrich), rifampicin (10µg/mL, Sigma-Aldrich) and gentamicin (10µg/mL, 
Sigma-Aldrich). After adding the antibiotics, the plates were incubated at 37°C for 24 h. 
 
2.4.2 Biofilm analysis 
 
To assess the influence of the antibiotics on the preformed biofilms, they were stained with: 
crystal violet (CV, Sigma-Aldrich), XTT ([2,3 bis(2-Methoxy-4-nitro-5-sulfophenyl)-5-
[(phenyalamino)carbonyl]-2H-tetrazolium hydroxide], Sigma-Aldrich,) or dymethylmethylene 
(DMMB, Sigma-Aldrich,).Crystal violet was used to determine the total biofilm biomass, XTT was 
used to assess the viability of the biofilm-associated bacteria and DMMB was used to stain biofilm’s 
matrix. 
Influence of antibiotics on Staphylococcus epidermidis biofilms 
27 
 
 
2.4.2.1 Crystal violet assay 
 
Supernatants were discarded and biofilms were gently washed twice with 250 µl PBS (pH 
7.4). After fixation with 400 µl ethanol (95º) for 20 min, the plates were dried. The biofilms were 
stained with 230 µl of Hucker’s CV during 15 min. The excess CV stain was removed by washing 
the plate under running tap water and the plates were dried. The bound CV was eluted by adding 
150 µl acetic acid (5% v/v in ddH2O) [56]. To measure the amount of CV that was bound, 100 µl 
of elute was transferred to a new 96-well microtitre plate and absorbance was read at 590nm using 
a spectrophotometer (Multilabel counter Victor3, PerkinElmer, USA). All samples were conducted 
in quadruplicate, and each experiment was repeated three times. 
 
2.4.2.2 XTT assay 
 
Biofilms were gently washed twice with 250 µl of PBS and then 250 µl of the XTT staining 
solution (containing 200 µg/mL XTT and 20 µg/ml phenazine methasulphate in 1/100 TSB) was 
added to each well. The microtiter plates were incubated in the dark for 2 h at 37 °C [55], [57]. 
The plates were then centrifuged for 5 min at 3000 rpm (Allegra X-22R Centrifuge, Belckman 
Coulter) and 100 µl from each well was transferred to a new microtiter plate and the absorbance 
read at 490nm. 
 
2.4.2.3 DMMB assay 
 
For the DMMB staining, two solutions were used: a staining solution and a decomplexation 
solution. Both solutions were prepared as described by Toté et al (2008) [58]. After discarding the 
supernatants, the plates were gently washed twice with 250 µl PBS. A volume of 250 µl of the 
DMMB staining solution was added to all wells and the plates were incubated at room temperature 
during 30 min, protected from light. Plates were then centrifuged at 2800 rpm for 20 min (Allegra 
X-22R Centrifuge, Belckman Coulter) and unbound DMMB was removed by rinsing with ddH2O. To 
each well 100 µl decomplexation solution was added and plates were incubated for 30 min at 
room temperature and protected from light [58]. After which 100 µl of the decomplexation solution 
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was transferred to a new microtitre plate and absorbance was measured at 630nm (Multiskan 
Ascent, Thermo Electron Corporation, Finland). 
 
2.5 Combined treatment of biofilms with DNase I and antibiotics 
 
Biofilms were grown for 24 h at 37 °C, the supernatants were discarded and biofilms were 
washed once. Each well was filled with 200 µl of antibiotic in 1/100 TSB and DNaseI (Sigma-
Aldrich) was added to a final concentration of 50 µg/mL [59]. Control wells were filled with 
antibiotic solutions in 1/100 TSB, without DNase I. Plates were incubated at 37°C for 24 h. 
Biofilms were washed twice with PBS and stained with CV as previously described. 
 
2.6 Extraction of eDNA 
 
Biofilm formation was carried out in a 6 well plate and 30 µl of a bacterial suspension of 0.5 
McFarland was added to 3 ml of TSB. After 24 h of incubation at 37°C, biofilms were washed once 
with PBS and the supernatant from each well was gently aspirated. Each well was treated with 
antibiotics diluted in 1/100 TSB. Control wells were filled only with 1/100 TSB. The plates were 
incubated for 24 h at 37°C. A volume of 2 ml of the supernatant was aspirated. Biofilms were 
gently washed three times with PBS, without disturbing the adherent biofilm and then scraped from 
the wells in the presence of 1 ml of a two times concentrated proteinase k buffer (Qiagen, Belgium). 
Biofilm samples of the same condition from different wells were combined together to extract 
extracellular DNA from [60], [61]. 
The pooled biofilm samples were homogenized by vortexing during 10 min. After 
homogenization, samples were mixed with 10 µg/mL proteinase K (Qiagen, Belgium) and the 
mixtures were incubated at 37°C for 1 h. Afterwards biofilm samples were filtered through 0.2 µm 
polyethersulfone membranes (PALL Life Sciences, USA) [61]. The extracellular DNA was 
precipitated using cetyltrimethylammonium bromide (CTAB)-DNA precipitation method [62]. In 
brief, samples were incubated with 1 volume of CTAB solution (1% CTAB in 50 mM Tris-10mM 
EDTA, pH 8.0) at 65°C for 30 min and then centrifuged at 5000 × g for 10 min at 4°C. The pellets 
were resuspended in 500 µl of NAES buffer (50mM sodium acetate pH 5.1, 10mM EDTA pH 8.0 
and 1% sodium dodecyl sulphate (SDS)). An equal volume of acidic phenol chloroform (pH 4.5, IAA 
(125:24:1), Ambion) was added to each preparation and then centrifuged for 5 min at 10.000 × 
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g. The upper layer of the preparation was precipitated with 520 µl of isopropylalcohol and 35 µl of 
sodium acetate (NaOAc 3 M, Sigma). Samples were centrifuged for 15 min at 10.000 × g. Lastly, 
the pellet was washed two times with ethanol, dried under vacuum for 25 min and resuspended 
in MiliQ water [62]. The DNA concentration was measured by determining the absorbance at 
260nm (𝐴260) and the purity of DNA was checked by determining the ratio of 𝐴260/𝐴280 using 
a spectrophotometer (NanoDrop 2000C, Thermo Fisher Scientific, Inc. Waltham, MA). The size of 
extracellular DNA was measured by gel electrophoresis. 
 
2.7 PIA dot-blot 
 
For this assay biofilms were grown on polyurethane catheter fragments of 0,7 cm in length 
(Multi-Lumen Central Venous Catheterization Set, Arrow International). The catheter fragments 
were suspended in 3 ml of the appropriated medium and 30 µl of 0.5 McFarland bacterial 
suspensions was added. Biofilms were grown at 37°C for 24 h, washed once and treated with 
antibiotics, again for 24 h at 37°C. 
The PIA dot-blot was conducted as follows. Catheter fragments were washed twice with PBS 
and transferred to an eppendorf tube containing 500 µl 0.5 M EDTA (pH 8.0). Samples were 
incubated at 100°C for 5 min and then centrifuged at 13.200 rpm for 10 min. A volume of 250 
µl of supernatant was treated with proteinase K (Qiagen, Belgium )at a final concentration of 2 
mg/mL for 1 h at 60°C and afterwards for 30 min at 80°C to inactivate the proteinase K [63]. A 
series of twofold dilutions of PIA extract was prepared in Tris-buffered saline [TBS: 20 mM Tris/HCl 
(pH 7.4), 0.9% (w/v) NaCl]). 
An Immobilon-P nitrocellulose membrane (Milipore Corporation, Ireland) was pretreated with 
methanol for 15 s, washed with ddH2O for 2 min and then with TBS for 5 min. The membrane was 
put on a Whatson filter paper, wetted with TBS and put in the vacuum blotter machine (DotBlot 
System/Acryl, Schleichor Schuell, Germany). A volume of 200 µl was transferred to the membrane 
using a vacuum blotter. The membrane was dried at 55°C for 2 h and then blocked in 50 ml 5% 
(w/v) BSA (bovine serum albumin), in TTBS (TBS plus 0.05% Tween 20) for 30 min [64]. The 
membrane was washed three times for 10 min each in TTBS and incubated overnight with 50 ml 
of Wheat germ agglutinin-horsradish peroxidase conjugate (WGA-HRP, 130 ng/mL Sigma) in 1% 
(w/v) BSA- TTBS at 4 °C. The membrane was washed three times with TTBS for 10 min each and 
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ECL Western blotting detection agent Plus (GE Healthcare, Italy) was added for 1 min. PIA was 
detected using the Bio-Rad ChemiDoc™ XRS (Bio-Rad, USA). 
 
2.7.1 gDNA extraction for detection of icaA operon 
 
S. epidermidis 1457 and S. epidermidis 1457ΔatlE were cultured overnight in 5 ml TSB. 
Cultures were harvested by centrifugation for 2 min at 13.200 rpm and further DNA isolation was 
performed with InstaGene Matrix (Bio-Rad, USA) according to the instructions of the manufacturer. 
Primers for the DNA amplification reaction are given in Table 1. Polymerase chain reaction 
(PCR) was performed on a GeneAmp PCR System 9700 (PE Applied Biosystems, USA). Cycling 
conditions were as follows: preheating for 5 min at 94°C, followed by 25 cycles of 30 s at 94°C, 
60 s at 60°C and 60 s at 72°C [65]. The PCR reaction mixture had a volume of 25 µl, and 
consisted of 12.5 µl of PCR Master Mix (Promega, USA), 10 µmol/L of each primer, 5.5 µl of 
nuclease-free water (Promega, USA) and 2 µl of DNA template. In the PCR, a positive control and 
a negative control were included. The positive control for icaA detection was gDNA from S. 
epidermidis 1457 and the negative control was distilled water. Amplified products were analyzed 
by 2% agarose gel electrophoresis. 
 
Table 2 Primers used in this study for icaA. 
Gene Sequence (5-3’) Primer 
PCR product 
size (bp) 
icaA 
CACGTGCTCTATGCTGGATG Forward 
761 
CACGTGCTCTATGCTGGATG Reverse 
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2.8 Scanning electron microscopy 
 
Scanning electron microscopy (SEM) was performed in order to check changes in biofilm 
structure and bacterial viability, after treatment with antibiotics. This experiment was only 
conducted for S. epidermidis 1457. 
Biofilms were grown on a cover slip disc in a 12 well-plate, with TSB as culture medium. The 
inoculums was prepared as described in 2.3. After 24 h of growth, biofilms were rinsed with PBS 
and treated with antibiotics for 24 h at 37°C, in 1/100 TSB. After 24 h, samples were rinsed with 
1 ml of PBS and fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylatebuffer pH 7.4 during 
2 h at room temperature. After primary fixation, samples were washed with 0.1 M cacodylatebuffer 
and postfixed for 2 h in 1% osmiumtetroxide. Biofilms were dehydrated by immersion in an 
ascending ethanol series 30%, 50%, 70% and 90% (v/v) for 5 min and 100% (v/v) ethanol for 3 x 
5 min. Additionally, the samples were dried with hexamethyldisilazane (HMDS, Sigma-Aldrich) for 
30 min with HMDS. [66]. The samples were then transferred to a vacuum desiccators for overnight 
drying. Samples were mounted on aluminum stubs with carbon tape, sputter-coated with platinum 
(Auto sputter coater, Agar Scientific) and observed with in a scanning electron microscope (Jeol, 
JSM 7401F). 
In order to assess biofilm morphology in each sample, three fields were used for image 
analysis. Images were recorded at magnifications of 1.000 x, 4.000 x, 10.000 x and 25.000 x. 
 
2.9 Statistical analysis 
 
Results were compared with XLSTAT software (Addinsoft, France). Significant differences were 
determined via one-way analysis of variance (one-way ANOVA). All tests were performed with a 
confidence level of 95%. 
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3.1 MIC determination 
 
The results of the antimicrobial susceptibility testing for all five S. epidermidis strains are 
summarized in Table 3. The results of the MIC determination were compared to the EUCAST 
clinical breakpoint tables for staphylococci to determine whether the strains were sensitive or 
resistant (Appendix 1: Clinical Breakpoints defined by EUCAST). All the strains were susceptible to 
the range of antibiotics used. 
 
 
 
Table 3 Determination of antibiotic susceptibilities by Staphylococcus epidermidis used strains in planktonic 
cultures (MIC) 
 
 
 
Strain 
Antibiotics concentrations (µg/mL) 
Vancomycin Teicoplanin Oxacillin Rifampicin Gentamicin 
S. epidermidis 1457 2 4 >128 >128 >128 
S. epidermidis 1457ΔatlE 1 >128 >128 >128 >128 
S. epidermidis 10b 1 1 >128 >128 >128 
S. epidermidis 567 1 1 >128 >128 >128 
S. epidermidis 567-1 2 2 >128 >128 >128 
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3.2 Evaluation of activity of antibiotics on biofilms 
 
Different methods were applied to evaluate the effects of the antibiotics treatment on the 
biofilm biomass, bacterial cell viability, changes on biofilms matrix and changes on biofilms 
structure. Antibiotics concentrations used corresponded to the serum peak concentrations. 
 
Figure 9 presents the results for CV staining of the biofilms after treatment with antibiotics. 
CV staining was used to quantify the total biofilm biomass which includes both cells and 
exopolymeric matrix. It was evident that all S. epidermidis strains produced biofilms. 
 
 
Figure 9 Absorbance values of S. epidermidis (Se) 1457, Se 1457atlE mutant, Se 10b, Se 567 and Se 567-1 
biofilms stained with crystal violet after treatment with vancomycin (Vanco), teicoplanin (Teico), oxacillin (Oxa), 
rifampicin (Rif) and gentamycin (Genta). Absorbance was measured at 590nm. Error bars represent 95% 
confidence interval. Statistical differences compared to control (TSB 1/100) are marked with an asterisk (one-
way ANOVA, p<0.05). 
 
Treatment with rifampicin and gentamicin were not effective in reducing the total biofilm 
biomass significantly on all strains (p>0.05). Treatment with vancomycin and teicoplanin treatment 
resulted in a significant increase of total biofilm biomass in all strains (p<0.05). Treatment with 
oxacillin reduced significantly the total biofilm biomass only for S. epidermidis 1457 (p<0.05). 
For S. epidermidis 1457ΔatlE, treatment with all antibiotics resulted in an increase in total 
biofilm biomass. The increase was significant for vancomycin, rifampicin and gentamicin (p<0.05). 
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Figure 10 presents the results of the XTT staining, showing changes in bacterial cell viability 
after treatment with antibiotics. Results show that all antibiotics applied reduced the bacterial cell 
viability. 
 
 
 
According to Figure 10, cell viability reduction was significant in all S. epidermidis strains for 
teicoplanin, rifampicin and gentamycin, except for S. epidermidis 1457. For that strain the 
reduction was only significant for teicoplanin and rifampicin. Treatment with vancomycin and 
oxacillin only reduced significantly bacteria viability for S. epidermidis 1457ΔatlE and for S. 
epidermidis 567. In fact for those two strains, all the antibiotics reduced bacteria viability 
significantly. 
Comparing the effect of antibiotics used against biofilm associated bacteria, it is shown that 
there are some significant differences between cell-wall active antibiotics (vancomycin, teicoplanin 
and oxacillin) and RNA and protein synthesis inhibitors (rifampicin and gentamicin, respectively). 
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Figure 10 Absorbance values XTT solutions obtained from adhesion of S. epidermidis (Se) 1457, Se 
1457atlE mutant, Se 10b, Se 567 and Se 567-1 strains after treatment with vancomycin (Vanco), 
teicoplanin (Teico), oxacillin (Oxa), rifampicin (Rif) and gentamycin (Genta). Absorbance was measured at 
490 nm. Error bars represent 95% confidence interval. Statistical differences compared to control (TSB 
1/100) are marked with an asterisk (one-way ANOVA,p<0.05). 
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Figure 11 summarizes the results of changes in the amount of biofilm matrix after treatment 
with antibiotics. 
 
 
Figure 11 Absorbance values DMMB solutions obtained from adhesion of S. epidermidis (Se) 1457, Se 1457atlE 
mutant, Se 10b, Se 567 and Se 567-1 strains after treatment with vancomycin (Vanco), teicoplanin (Teico), 
oxacillin (Oxa), rifampicin (Rif) and gentamycin (Genta). Absorbance was measured at 630 nm. Error bars 
represent 95% confidence interval. Statistically different compared to control (TSB 1/100) (one-way ANOVA, 
p<0.05). 
 
 
As it is possible to observe in Figure 11, vancomycin and teicoplanin significantly increased 
the amount of biofilms matrix present (p<0.05). For the other treatments (oxacillin, rifampicin and 
gentamycin), the increasing or reduction was not significantly shown. However, for S. epidermidis 
1457ΔatlE, there is no increase in DMMB staining. For this strain it is remarkable that the amount 
of biofilms matrix increases after treatment with oxacillin and rifampicin, and reduces after 
treatment with gentamicin. 
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SEM analysis was performed to visualize changes in S. epidermidis 1457 biofilms morphology 
after treatment with antibiotics. SEM results are shown on Figure 12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 Representative scanning electronic microscopy photographs of S. epidermidis 1457 biofilms after 
treatment with: lane I- control (TSB 1/100); II- Vancomycin; III- Teicoplanin; IV- Oxacillin; V- Rifampicin and VI- 
Gentamicin. Experiments were performed in triplicate and biofilms were viewed at 1000x magnification 
(column a), 4000x magnification (column b) and 10000x magnification (column c).  
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Vancomycin treatment resulted in a rougher biofilm (Figure 12 IIa vs. Ia), with likely more 
bacteria attached (Figure 12 IIb vs Ib). Damaged bacteria can be identified from the creases 
(marked with red squares). Also treatment with teicoplanin resulted in damaged bacteria. The 
biofilms treated with teicoplanin look very similar to treatment with TSB 1/100 (Figure 12 IIIb vs 
Ib). Treatment with oxacillin (Figure 12 IV) made bacteria detach from the biofilm but the matrix 
was left behind. Also rifampicin treatment (Figure 12 V) resulted in bacterial detachment with matrix 
remaining, though to a lesser extent then oxacillin treatment. Gentamicin treatment finally (Figure 
12 VI) gave a smooth biofilm containing the same amount of bacteria and matrix (Figure 12 VIb), 
or more (Figure 12 VIc) then the TSB 1/100 treated biofilms. 
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3.3 Influence of antibiotic treatment on biofilm matrix DNA and PIA 
 
To explain the previous observations, antibiotic induced changes in the composition of the 
biofilm matrix were considered with a focus on extracellular DNA (eDNA) and PIA. 
 
3.3.1 Extracellular DNA 
 
Figure 13 shows the proportional reduction of the total biofilm biomass after treatment with 
DNaseI plus antibiotics, relative to the total biofilm biomass after treatment with only antibiotics.  
 
Figure 13 Percentual reduction of biofilm biomass assayed with CV staining. Absorbance reduction was 
compared between antibiotic treated (AB) and DNaseI combined with antibiotic treated biofilms (DNaseI+AB). 
Antibiotics (AB) used were Vanco – vancomycin; Teico- teicoplanin; Rif- rifampicin; Oxa- oxacillin and Genta- 
gentamicin. 
 
In Figure 13 it is possible to observe that treatment of biofilms with DNaseI combined with 
antibiotics significantly reduced the total biofilms biomass of all strains and with all the tested 
antibiotics (p<0.05). That reduction is more notable for treatments with rifampicin for S. 
epidermidis 567 and with rifampicin, oxacillin and gentamycin for S. epidermidis 567-1. Those 
antibiotics allowed an up to 60 % reduction of biofilm biomass on the strains referred. 
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The effects of only antibiotic treatment on the excretion of DNA (eDNA) was quantified by 
extracting the eDNA out of the matrix. eDNA was quantified relatively by agarose gel electrophoresis 
and absolutely by spectrophotometric measurement. 
 
Figure 14 shows a picture of the agarose gel electrophoresis of eDNA extracted from 24h old 
biofilms. That assay was done to check for the presence and amount of eDNA in all strains without 
any treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It appeared that eDNA was present in biofilms of all strains except those produced by S. 
epidermidis 1457ΔatlE (marked with a red arrow). S. epidermidis 10b showed a bigger amount of 
eDNA, represented by a more intense band on the agarose gel. 
 
 
 
 
Figure 14 Gel electrophoresis of 
extracellular DNA extracted from all S. 
epidermidis strains used grown only in 
culture medium (Se – S. epidermidis). 
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Figure 15 shows the images of the electrophoreses of eDNA extracted from the biofilms of all 
strains after treatment with antibiotics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to Figure 15 treatment with antibiotics had an influence on eDNA excretion. 
Different treatments on the same strain produced different changes on the amounts of eDNA 
extracted.  For S. epidermidis 1457 it is notable that treatment with teicoplanin and oxacillin 
renders an increase on the amount of eDNA extracted. For S. epidermidis 567 and S. epidermidis 
567-1, the amount of eDNA extracted is really similar with and without treatment. Except for S. 
epidermidis 567 treated with oxacillin and rifampicin, that the amount of eDNA extracted is 
increased and decreased, respectively. For S. epidermidis 10b the amount of eDNA extracted is 
increased only in treatment with oxacillin, gentamycin and rifampicin, meaning that treatments 
with vancomycin and teicoplanin had no effect on the amount of eDNA excretion. 
Lastly, for S. epidermidis 1457ΔatlE it was noticeable that no eDNA extracted was shown for 
not treated biofilms. Only for treatments with rifampicin and gentamycin it is possible to see an 
amount of eDNA excretion by the biofilm. 
Figure 15 Gel electrophoresis of extracellular 
DNA extracted from different strains (Se – S. 
epidermidis). Lanes represent the treatments 
used: 1- TSB (1/100); 2- Vancomicin; 3- 
Teicoplanin; 4- Oxacillin; 5- Rifampicin; 6-
Gentamicin. 
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3.3.2 PIA (PIA dot-blot) 
 
The effects of antibiotic treatments on the biofilm matrix with regard to the PIA content were 
assessed by PIA dot-blot.  
Figure 16 shows the relative amounts of PIA in the biofilm matrix after treatment with 
antibiotics compared to the control (biofilms formed only in TSB (1/100)). 
 
 
Figure 16 Relative amounts of PIA on biofilms were determined using a PIA dot blot assay after treatment with 
antibiotics: Vanco- Vancomycin; Teico- Teicoplanin; Oxa- Oxacillin; Rif- Rifampicin and Genta- Gentamicin. To 
determine the relative amounts of PIA, it was defined that the amount of PIA produced by each strain 
individually when treated with TSB (1/100) as 100% and expressed all other amounts as relative to the amount 
on that TSB (1/100) treatment. 
 
 
Interestingly, for S. epidermidis 1457ΔatlE it was not possible to determine the relative 
amount of PIA because that strain did not show any PIA on the dot blot assay performed. 
For S. epidermidis 567-1 treatment with vancomycin, oxacillin, rifampicin and gentamicin 
(Figure 16) there was an enhancement in the production of PIA up to more than 20% comparing 
with the absence of antibiotics treatment. For S. epidermidis 1457 and S. epidermidis 10b, 
vancomycin and teicoplanin treatment showed a higher amount of PIA when compared with 
treatment with the other antibiotics, although the difference is small. For S. epidemidis 567 the 
amount of PIA on vancomycin treatment is shown to be really reduced compared with the other 
treatments.  
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Figure 17 shows a representative dot blot assay for S. epidermidis 1457.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Figure 17 it is possible to see the differences in the amount of PIA between treatments. 
Results shown are comparable with those shown on Figure 16. Treatments with vancomycin and 
teicoplanin showed a higher amount of PIA, notable by the darker spot shown on 1/100 dilution 
(lane 3).  
 
 
S. epidermidis 1457 ΔatlE was DMMB stained but did not show any PIA on dot-blot assay. 
Since PIA is the major component of the biofilms matrix and was not shown on PIA dot blot even 
though the mutant strain was DMMB stained, it was important to check if this strain contained the 
ica operon, needed for the production of PIA. For this purpose a PCR on icaA was conducted on 
the gDNA extracted from S. epidermidis 1457 ΔatlE and S. epidermidis 1457. Agarose gel 
electrophoresis of the PCR products was analysed (Figure 18).  
 
 
Figure 17 Representative S. epidermidis 1457 dot blot 
for determining spot volumes on each treatment: lane 
TSB (1/100)- control; Vanco- Vancomycin; Teico- 
Teicoplanin; Oxa- Oxacillin; Rif- Rifampicin and Genta- 
Gentamicin. Columns represent the different dilutions 
used: 1- 1/10; 2- 1/50; 3- 1/100. 
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Comparing the results obtained for S. epidermidis 1457 and for S. epidermidis 1457 ΔatlE 
shown on Figure 18 it is possible to conclude that the mutant strain possesses the icaA operon. 
That result sustained the hypothesis that this strain should have the ability to produce PIA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 Gel electrophoresis result of 
S. epidermidis 1457 and S. epidermidis 
1457 ΔatlE PCR on the icaA gene to 
check for its presence. 
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Staphylococcus epidermidis is the most frequently isolated species of the CoNS group. S. 
epidermidis is found on skin and mucous membranes of humans and other organisms, 
representing an important part of its normal microflora [16]. Previously regarded as relatively 
innocuous, has gained significant interest in recent years and has become one of the leading 
causes of infections related to implanted medical devices. Those infections have especial interest 
among immunocompromised, immunosuppressed and critically ill patients [15], [19], [39]. 
Treatment of S. epidermidis infections has become very difficult due to the increasing 
resistance to antibacterial agents. Antimicrobial resistance has a significant impact on patient 
outcome by enhancing virulence, delaying the administration of therapeutic medicines leading to 
increased morbidity and mortality [19]. It is a serious problem particularly notable in S. epidermidis, 
since many clinical isolates of this organism are resistant to up to eight different antibiotics. In 
addition to this problem is the fact that the major virulence factor of S. epidermidis is biofilm 
formation and that cells in biofilms are normally more resistant to antibiotics than planktonic cells, 
making drug resistance in a CoNS infection an even more serious problem [15], [16]. Therefore, 
it is crucial to understand the mechanisms of action and the changes promoted by antibiotics on 
biofilms, in order to better address this problem of antibiotic resistance.  
 
4.1 Antibiotic susceptibility 
 
Firstly, it became important to determine if the chosen antibiotics had an effect on the S. 
epidermidis strains used. Therefore, an assay to determine the MIC concentration for planktonic 
cells was carried out. Although standard antimicrobial susceptibility testing, which challenges 
planktonic (suspended) cells with an antimicrobial agent, will not accurately predict the efficacy of 
an agent against biofilm associated organisms, it is important in order to understand if the strain 
is naturally susceptible to the antibiotic or not. 
To evaluate the efficacy of the antibiotics used in this study, a concentration range was chosen. 
These values were well defined in the standard [67] endpoints for antimicrobial susceptibility 
testing and thus enable evaluation of the efficacy of antibiotics against planktonic microorganisms. 
Results shown on Table 3 make it is possible to conclude that all the S. epidermidis strains used 
were susceptible to the antibiotics. It is important to note that the results are consistent with clinical 
breakpoints defined by EUCAST for S. epidermidis (Appendix 1: Clinical Breakpoints defined by 
EUCAST) [67]. 
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Regarding the results for each strain separately, for S. epidermidis 1457 and S. epidermidis 
10b the results are according to the expect comparing with the literature [68], [45]. MIC results 
for S. epidermidis 1457ΔatlE treated with vancomycin show to be different from the MIC for the 
wild-type strain. According to Hello et al. [69] that was not an expected result.  In their study it was 
found that the altE mutant susceptibility to vancomycin was similar to the wild-type strain 
susceptibility. That difference found can maybe be explained by the fact that the mutant strain  
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4.2 Evaluation of antibiotics activity on biofilms 
 
The pathogenesis of medical device infections associated with S. epidermidis is characterized 
by the microorganism’s ability to colonize the surface of implanted medical devices by the 
formation of highly resistant biofilms [19]. Biofilm formation is, as mentioned, the major virulence 
factor in S. epidermidis infections and therefore it is of especial interest to address the mechanisms 
of action of the antimicrobial treatment applied. In this study, to evaluate the effect of antibiotics, 
it was necessary to discriminate between the biofilm matrix and the bacteria living within it. That is 
from a major importance because it is documented that when an antibiotic only acts on the slime 
layer, biofilm bacteria will start forming a new matrix almost immediately and if only biofilm bacteria 
are killed, the remaining matrix is predestined to become re-colonized [70]. 
The CV, XTT and DMMB assays were used in this study in order to determine the influence of 
antibiotic treatments on the biofilms, whether on the biofilm biomass, bacteria viability and biofilms 
matrix, respectively. The different antibiotics used and its different mechanisms of action are shown 
in Table 1 and explained in Chapter 1.5.1. 
 
In particular, CV staining was used to evaluate the effect of antibiotics treatment on biofilms, 
regarding the changes on total biofilm biomass. This assay was important in order to conclude if 
the antibiotics had an effect on increasing or decreasing the total biofilm biomass formed compared 
to the control (cells growing only in the presence of TSB 1/100). Results obtained in the CV assay 
allowed to conclude that all S. epidermidis strains produced biofilms (Figure 9), as it was expected 
[15], [17]. 
Evaluating the strains capacity to form biofilms without any antibiotic treatment, it was possible 
to detect some changes in relation to the expectable results. For instances, S. epidermidis 1457 
ΔatlE formed more biofilm biomass than S. epidermidis 1457 (its wild-type). Since the extracellular 
DNA is found as a major component required for initial bacterial attachment to surfaces, as well 
as for the subsequent early phase of biofilm development by S. epidermidis, it was expectable that 
the mutant strain formed less biofilm. That was the expectable result because the release of 
extracellular DNA is known to be mainly caused by the activity of the autolysin AtlE. Since S. 
epidermidis 1457 ΔatlE lacks on the atlE gene it was supposed to have less bacteria attached to 
the surface [27]. These results can maybe be explained by the media growth dilution used for the 
wild-type strain and not on the mutant strain, giving it more nutrients to colonize the surface of the 
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plate and reproduce. That difference in the growth media is related to the protocol for S. 
epidermidis 1457 ΔatlE biofilms cultivation referred by Qin et al. [27] 
Results presented in Figure 9 also showed that biofilms of S. epidermidis 567 and S. 
epidermidis 567-1 have a very similar biomass. That result was not expectable, according to the 
literature, since the agr mutant, S. epidermidis 567-1, in previous studies exhibited a stronger 
biofilm formation [55]. Since the aim of this study was to evaluate the influence of antibiotics 
treatment on S. epidermidis biofilms, those results are of less importance and are only related to 
the control biofilms. 
In fact, in the same strain the differences noted on the biofilm biomass were caused by the 
antibiotics treatments applied. Different antibiotics had different effects on each strain. For 
instances, by CV staining on Figure 9, it is noticeable that vancomycin and teicoplanin treatments 
had an effect, significantly increasing the total biofilm biomass on all strains. That result has already 
been documented by Hsu [44]. This vancomycin and teicoplanin tolerance of S. epidermidis was 
attributed to the poor activity of glycopeptides related to a diminished antimicrobial effect on S. 
epidermidis cells in biofilm already documented by Farber et al. [71]. 
The biofilm biomass enhancement caused by vancomycin and teicoplanin, in this study, can 
be explained by an increased excretion of extracellular DNA or and increased production of PIA 
caused by the action of those antibiotics on the cell wall. Increased excretion of eDNA enhance 
biofilm formation and adhesion cell-to-cell. The DNA in the extracellular space, released by the 
action of the antibiotics, can aggregate, therefore enhancing biofilms formation. The suggested 
increasing on PIA’s production can be related to the rupture of the cell wall due to the antibiotics 
action. That can enhance PIA’s production and creation of a linked connection between bacterial 
cells [44]. 
Only for S. epidermidis 1457 oxacillin treatment decreased significantly the total biofilm 
biomass formed. That can imply that this antibiotic has a bigger antimicrobial effect on reducing 
the total biofilm biomass formed compared to the other two cell wall active antibiotics, for this 
strain in particular.  
S. epidermidis 1457 ΔatlE showed also more biofilm biomass comparing with all the other 
strains used in this work, except for S. epidermidis 567 treated with vancomycin and teicoplanin. 
Also in S. epidermidis 1457ΔatlE strain, treatment with teicoplanin, rifampicin and gentamycin had 
a significant increase on biofilm biomass. As this strain lacks on atlE gene, the biofilm formed 
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cannot be explained by the extracellular DNA release [27]. So, that may imply that the large amount 
of biofilm formed is due to the increased production of PIA. 
 
The crystal violet assay has been extensively used, but likely because the estimated biomass 
does not distinguish between dead or living bacteria, it is not very informative when not 
complemented with a viability assay. Even with the increasing biofilms biomass detected it was 
important to determine if the antibiotics had an antimicrobial effect on the biofilm associated 
bacteria. That is why it was important to add the XTT assay. This method allows to stain only active 
bacteria cells in the formed biofilm, which means that it quantifies the bacteria in biofilms that have 
the capacity to continue to grow and proliferate the infection. According to Figure 10, it was 
expected all antibiotic treatments reduced bacteria viability for all strains since they were proven to 
be susceptible to the antibiotics in use by the MIC determination. Those results make it possible 
to conclude that all the antibiotics were successful on killing biofilm associated bacteria, suggesting 
that the increasing CV staining found on the biofilms, and therefore a large amount of biofilm 
biomass, had to be related to the increased amount of dead cells and biofilms matrix. 
Comparing the effects on killing biofilm associated bacteria by different antibiotics, it is 
possible to conclude that for S. epidermidis 567 and S. epidermidis 10b, teicoplanin, rifampicin 
and gentamicin had a similar effect. 
For S. epidermidis ΔatlE comparing to the wild-type, it is possible to see that the mutant strain 
was more susceptible to killing by antibiotics. In fact, it is possible to conclude that cell-wall active 
antibiotics had an increased effect on bacteria killing on that mutant strain. That result is supported 
by the literature that reported an implication of AtlE loss in the tolerance of S. epidermidis to cell 
wall active antibiotics [68]. 
 
To the CV and XTT staining methods, it was added the DMMB staining method. The aim of 
this staining method was the evaluation of the changes on the biofilms matrix in addition with the 
other two assays performed. DMMB is a cationic dye used for quantification of sulphated 
polysaccharides, more specifically glycosaminoglycans (GAGs) in biological samples. As there is 
structural similarity between PIA and GAGs, it was hypothesized by Toté et al. [58] that DMMB 
could be used for the specific detection of S. aureus biofilm matrix. Since PIA is also the major 
component of S. epidermidis biofilms matrix, it was also used in this study to detect PIA’s content 
on the biofilms [72]. As seen before treatment, cell-wall active antibiotics, as vancomycin and 
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teicoplanin, had an effect on increasing biofilms’ biomass. With the DMMB, Figure 11, it is possible 
to see that treatments with those antibiotics had an obvious effect on increasing the amount of 
biofilms matrix. Those cell-wall active antibiotics act on the bacteria cell-wall causing the membrane 
rupture and enhancing matrix production [73]. 
 
Besides the effects on biofilms biomass, bacteria viability and biofilms matrix, the changes 
promoted by antibiotics treatments in biofilms were visualized by scanning electron microscopy 
(SEM). The changes on S. epidermidis morphology were evaluated using 1457 S. epidermidis 
strain. This strain is known as a biofilm forming strain that produces a thick biofilm [53] and thus 
it was chosen to better illustrate the effects of the antibiotics on the biofilm structure, cell viability 
and the biofilm matrix through SEM analysis (Figure 12). According to the results, vancomycin 
treatment resulted in a rougher biofilm (Figure 12 IIa vs. Ia), with likely more bacteria attached 
(Figure 12 IIb vs Ib). It is possible to visualize some damaged bacteria but the main conclusion is 
that treatment with this antibiotic promoted a cell wall thickening. That result has been already 
documented by Hsu [44], that proved that treatment with vancomycin enhanced the biofilm 
thickness. That result for vancomycin treatment is also supported by the results obtained after CV, 
XTT and DMMB staining. This strain showed an higher biofilm biomass formed after CV staining, 
with a small effect on bacteria killing assayed by XTT staining. Even with DMMB staining, this strain 
showed a significant increase on the biofilm matrix after treatment with vancomycin. 
Treatment with teicoplanin had an effect on increasing biofilms thickness even if in a less 
extent as vancomycin treatment. It also resulted in damaged bacteria. The biofilms treated with 
teicoplanin look very similar to treatment with TSB (1/100) (Figure 12 IIIb vs Ib). These SEM results 
are in agreement with the previous results obtained in CV, XTT and DMMB staining. It is noticeable 
the increased amount of biofilms biomass and biofilms matrix, as assayed by CV and DMMB 
staining methods. 
Treatment with oxacillin (Figure 12 IV) and rifampicin (Figure 12 V) resulted in bacterial 
detachment with matrix remaining. Gentamicin treatment finally (Figure 12 VI) gave a smooth 
biofilm containing the same amount of bacteria and matrix or more then the TSB (1/100) treated 
biofilms. These results are in accordance with the ones obtained after the staining methods applied. 
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4.3 Influence of antibiotic treatment on biofilm matrix DNA and PIA 
 
As mentioned by Qin et al. [27], in the process of biofilm formation, the cell-cell aggregation 
and the formation of a multilayered architecture, some matrix components such as eDNA and PIA 
are of utmost importance. In this study and to explain the changes on the biofilms after treatment 
with antibiotics it was important to assess the induced changes. Therefore it was evaluated if the 
changes on biofilms matrix regarding the extracellular DNA (eDNA) and the PIA’s content. 
 
The eDNA is found as a major component required for initial bacterial attachment to surfaces, 
as well as for the subsequent early phase of biofilm development. In antibiotic treatments it is 
important to understand if the eDNA release and consequent biofilm formation is affected. In this 
study, biofilms were treated with a combination of antibiotics plus DNase I and compared with the 
antibiotics treatment only. Previous studies showed that DNase I inhibits S. epidermidis biofilm 
formation, which suggests that eDNA can function as an adhesive component of the S. epidermidis 
biofilm matrix [27], [35]. Evidence suggests that eDNA is generated in S. epidermidis populations 
through AtlE-mediated lysis of a subpopulation of the bacteria, and the extracellular DNA promotes 
biofilm formation of the remaining population [27].  
From results shown on Figure 13, it was found that DNase I plus antibiotics treatment 
efficiently inhibited biofilm formation by S. epidermidis 567 and 567-1 strains. For S. epidermidis 
567 the inhibition was more noticeable for DNase I treatment plus rifampicin. For S. epidermidis 
567-1 the inhibition was higher for the combined treatment of DNase I plus rifampicin, gentamicin 
and oxacillin. That data indicates that the destruction of eDNA by DNase I leads to a decrease in 
the matrix, and as a result, antibacterial agents act more effectively to reduce the biofilm biomass 
as it was previously proved Tetz et al. [59].  
Although the percentual reduction was higher for the antibiotics referred above, also for the 
other strains and other treatments used, the percentual reduction was up to 30%. Only for S. 
epidermidis 1457 treated with teicoplanin and S. epidermidis 567 treated with vancomycin, the 
reduction was lower.   
There are evidences that release of extracellular DNA is mainly caused by the activity of the 
autolysin atlE [27]. So, as it was expected, for S. epidermidis 1457ΔatlE there was no eDNA shown 
on Figure 14. The S. epidermidis 1457ΔatlE lacks on the atlE gene. In Figure 15, for S. epidermidis 
atlE mutant strain there is some eDNA shown on treatments with rifampicin and gentamicin. That 
Influence of antibiotics on Staphylococcus epidermidis biofilms 
56 
 
result can be explained because treatment with antibiotics renders the bacteria more sensitive to 
lysis during eDNA extraction procedure. Lysis of the bacteria, possibly during vortexing, can mean 
that it is not only eDNA that is being extracted but also intracellular DNA. That is the reason why 
the results from this method are not completely reliable. 
 
Besides the activity on eDNA release, antibiotics treatment also promoted PIA’s production. 
That can also be one of the explanations for the antibiotics activity on biofilms. PIA was found as 
the major component involved in intercellular adhesion, essential for the accumulation of the 
biofilms [19]. That is why it is so important to determine the effect of the antibiotics treatment on 
PIA’s production because it is related to the capacity of the biofilms to accumulate on a surface. 
In PIA dot-blot assay it was shown that for S. epidermidis 567-1, treatment with vancomycin, 
oxacillin, rifampicin and gentamicin (Figure 16) induced an enhancement in the production of PIA 
up to more than 20% comparing with the absence of antibiotics treatment. Those results can 
explain the increased amount of biofilm formed by that strain showed on Figure 9, especially for 
vancomycin treatment. In fact, these results allow to conclude that the amount of biofilm biomass 
formed was mainly due to the increased production of PIA, promoted by that cell-wall active 
antibiotic. Those results are in concordance with previous studies [44]. In a less extent difference, 
for S. epidermidis 1457 and S. epidermidis 10b, vancomycin and teicoplanin treatment showed a 
higher amount of PIA when compared with treatment with the others antibiotics. That result can 
be related with an enhancing production of PIA promoted by the action of those  For S. epidemidis 
567 the amount of PIA on vancomycin treatment is shown to be really reduced compared with the 
other treatments. That implies that the increased biofilm formation was due to an increased 
excretion of eDNA promoted by that antibiotic on 567 S. epidermidis strain. 
In this assay, it was not possible to assess the amount of PIA on S. epidermidis 1457 ΔatlE. 
In fact, that strain was DMMB stained with an higher amount of matrix compared to the wild-type 
strain but did not show any PIA on dot-blot assay. For that reason it was important to check if this 
strain contained the icaA operon, needed for the production of PIA. Results shown on Figure 18 
proved that the mutant strain possesses the icaA operon and therefore should be able to produce 
PIA. Even though the icaA operon is present it is possible that it is not expressed. As documented 
by Conlon et al. [74] the icaR gene can be the explanation for the regulation of icaA. IcaR product 
is a transcriptional repressor which plays an adaptive role in S. epidermidis biofilm formation by 
modulating the regulation of ica expression. 
Influence of antibiotics on Staphylococcus epidermidis biofilms 
57 
 
Another data is related to the fact that this mutant strain produced a large amount of biofilm 
biomass even in comparison with the other strains. That result had already suggested that the 
increased biofilm biomass formed assayed by CV staining, was related with the increased amount 
of PIA’s production. It can be assumed that the strains is icaADBC- and so as a PIA-independent 
mechanism of biofilm formation. That result have already been documented for other S. 
epidermidis strains and Kogan et al. [11] suggested that in the biofilm formation it was involved 
the product of a limited proteolysis of the accumulation-associated protein (Aap). 
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Chapter 5 Conclusion and future perspectives 
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Staphylococcus epidermidis is the most frequently isolated species of the CoNS group. 
Previously regarded as relatively innocuous, has gained significant interest in recent years and has 
become one of the leading causes of infections related to implanted medical devices. Treatment 
of S. epidermidis infections has become very difficult due to the increasing resistance to 
antibacterial agents. It is a serious problem particularly notable in S. epidermidis, since many 
clinical isolates of this organism are resistant to up to eight different antibiotics. Therefore, it is 
crucial to understand the mechanisms of action and the changes promoted by different antibiotics 
on biofilms, in order to better address this problem of antibiotic resistance. So, this work aims to 
evaluate the influence of antibiotics on S. epidermidis biofilms in terms of changes in matrix 
composition after treatment, regarding the eDNA and the PIA content. 
Regarding the MIC results, it was proven that all the S. epidermidis strains used were 
susceptible to all the antibiotics chosen for this study (vancomycin, teicoplanin, oxacillin, rifampicin 
and gentamicin). Those results for planktonic cells were also supported by the results obtained 
after XTT staining assay since all the antibiotics were successful on killing biofilm associated 
bacteria. 
In relation to the biofilm biomass content and changes, results of crystal violet assay made it 
possible to conclude that all S. epidermidis strains produced biofilms and that the changes on 
biofilm biomass were promoted by antibiotics treatment. It was noticeable that vancomycin and 
teicoplanin treatments had an effect, significantly increasing the total biofilm biomass on all strains. 
Those glycopeptide had an effect on increasing biofilms biomass and by DMMB staining methods 
it become obvious that they had an effect on increasing the amount of biofilms matrix because 
they promote the membrane rupture and enhanced matrix production. 
The changes promoted by antibiotics treatments in biofilms were visualized by scanning 
electron microscopy (SEM) on 1457 S. epidermidis strain. This strain was chosen because it forms 
a thicker biofilm and thus better illustrates the effects of the antibiotics on the biofilm structure, 
cell viability and the biofilm matrix through SEM analysis. According to the results, vancomycin and 
teicoplanin treatments resulted in a rougher biofilm, proving that treatment with vancomycin 
enhanced the biofilm thickness. 
Concerning the differences promoted by antibiotics, the influence on matrix components such 
as eDNA and PIA were evaluated. From results it was found that DNase I plus rifampicin and 
gentamicin efficiently inhibited biofilm formation. That data indicated that the destruction of eDNA 
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by DNase I leads to a decrease in the matrix, and as a result, antibacterial agents act more 
effectively to reduce the biofilm biomass on protein synthesis inhibitor antibiotics. 
Besides the activity on eDNA release, antibiotics treated biofilms were also tested by its PIA’s 
production pattern changes after antibiotic treatment. The results obtained allowed the conclusion 
that the increased biofilm biomass formed was mainly due to the increased production of PIA, 
promoted by glycopeptide antibiotics, as vancomycin and teicoplanin. 
In general, it was possible to conclude that S. epidermidis biofilms from different strains 
showed an enhanced resistance to the application of treatment with glycopeptide antibiotics. Those 
antibiotics are normally reserved for use against multi-resistant staphylococci, however from this 
study data and from previous studies, it is at major importance to have a better understanding of 
the resistance mechanisms and the look for different alternatives. 
As future work, it would be interesting to perform an analysis with further precision to the S. 
epidermidis 1457 ΔatlE that lacks on the atlE gene, seen as an important component of biofilm 
formation. It would be as of major interest to better understand the mechanisms of biofilm 
formation regarding that strain and perform different and more precise analysis to determine what 
are the mechanisms that prevent PIA’s production by that strain. 
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Appendix 
Appendix 1: Clinical Breakpoints defined by EUCAST 
 
A.1 Clinical breakpoints for a) Vancomycin; b) Teicoplanin; c) Oxacillin; d) Rifampicin and e)  
Gentamicin, against Staphylococcus epidermidis. 
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